Renalytix (
RENX · AIM · Health Care · mcap £39m · 5.3p
Financials · LTM to 31 Dec 25
Source: results 26 Mar 26 ↗
Going-concern uncertainty
- Revenue
- £2.5m
- Operating profit
- −£12.8m
- Net income
- −£15.2m
- Free cash flow
- −£9.9m
- Net cash
- £1.0m
- Market cap
- £35.5m
- EV / EBIT
- –
- FCF yield
- −27.8%
- Price / book
- –
Latest half-year · H1 Dec 25 vs H1 Dec 24
results 26 Mar 26 ↗
- Revenue
- £1.2m +19%
- Operating profit
- −£5.3m prior −£5.8m
- Net income
- −£6.0m prior −£6.7m
- Cash from operations
- −£4.0m prior −£8.0m
Extracted automatically from the company's results announcements; check the source before relying on a figure. Not investment advice.
Latest report: H1 Dec 25 (six months to 31 Dec 25), published 26 Mar 26 · read the results ↗
£m unless stated · newest first · italic = calculated (LTM, H2 = FY − H1) · hover a value for its source
| LTM Dec 25 | FY Jun 25 | |
|---|---|---|
| Revenue | 2.5 | 2.3 |
| Gross profit | 1.1 | 0.9 |
| Adjusted EBITDA | (10.0) | (10.8) |
| Operating profit | (12.8) | (13.3) |
| Share-based payments | 2.7 | 2.5 |
| Profit before tax | (16.2) | (16.9) |
| Net income (owners) | (15.2) | (15.8) |
| EPS basic | (2.6p) | (5.1p) |
| EPS diluted | (2.6p) | (5.1p) |
| H1 Dec 25 | vs H1 Dec 24 | H2 Jun 25 | H1 Dec 24 | |
|---|---|---|---|---|
| Revenue | 1.2 | +19% | 1.3 | 1.0 |
| Gross profit | 0.6 | +54% | 0.5 | 0.4 |
| Adjusted EBITDA | (4.8) | n/m | (5.2) | (5.6) |
| Operating profit | (5.3) | n/m | (7.5) | (5.8) |
| Share-based payments | 0.4 | +93% | 2.2 | 0.2 |
| Profit before tax | (6.0) | n/m | (10.2) | (6.7) |
| Net income (owners) | (6.0) | n/m | (9.1) | (6.7) |
| EPS basic | (1.5p) | – | (1.1p) | (4.0p) |
| EPS diluted | (1.5p) | – | (1.1p) | (4.0p) |
| LTM Dec 25 | FY Jun 25 | |
|---|---|---|
| Cash from operations | (9.9) | (13.8) |
| Shares issued | 10.3 | 15.1 |
| Latest Dec 25 | FY Jun 25 | |
|---|---|---|
| Property, plant & equipment | 0.1 | 0.1 |
| Inventories | 0.2 | 0.1 |
| Trade receivables | 1.0 | 0.4 |
| Cash | 4.5 | 2.6 |
| Current assets | 6.3 | 4.2 |
| Total assets | 7.4 | 4.4 |
| Trade payables | 3.9 | 3.5 |
| Lease liabilities, current | 0.1 | – |
| Current liabilities | 4.0 | 3.5 |
| Borrowings, non-current | 3.5 | 6.0 |
| Lease liabilities, non-current | 0.7 | – |
| Total liabilities | 8.2 | 9.5 |
| Total equity | (0.9) | (5.1) |
| H1 Dec 25 | H2 Jun 25 | H1 Dec 24 | |
|---|---|---|---|
| Property, plant & equipment | 0.1 | 0.1 | 0.2 |
| Inventories | 0.2 | 0.1 | 0.3 |
| Trade receivables | 1.0 | 0.4 | 0.4 |
| Cash | 4.5 | 2.6 | 7.3 |
| Current assets | 6.3 | 4.2 | 8.9 |
| Total assets | 7.4 | 4.4 | 9.1 |
| Trade payables | 3.9 | 3.5 | 3.7 |
| Lease liabilities, current | 0.1 | – | – |
| Current liabilities | 4.0 | 3.5 | 3.7 |
| Borrowings, non-current | 3.5 | 6.0 | 6.5 |
| Lease liabilities, non-current | 0.7 | – | – |
| Total liabilities | 8.2 | 9.5 | 10.2 |
| Total equity | (0.9) | (5.1) | (1.1) |
Line items extracted automatically from each results announcement; when a later report restates a period, the later figure is shown. LTM and H2 are calculated from reported periods. Check the source before relying on a figure.
Company filings. Not investment advice.